Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common and lethal cancer worldwide. Radiotherapy (RT) is widely used at all stages of LUAD, and the development of immunotherapy substantially enhances the survival of LUAD patients. Although the emerging treatments for LUAD have improved prognosis, only a smal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Han, Linzhi, Shi, Hongjie, Luo, Yuan, Sun, Wenjie, Li, Shuying, Zhang, Nannan, Jiang, Xueping, Gong, Yan, Xie, Conghua
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Cancer Biology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7774727/
https://ncbi.nlm.nih.gov/pubmed/33098370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3561
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi